1. Johnson Fistel is investigating Ardent for potential securities law violations. 2. Ardent reported a $43 million revenue reduction and increased reserves by $54 million. 3. The company's stock declined significantly following these financial disclosures.
The significant revenue reduction and reserve increase may undermine investor confidence, similar to past instances where financial restatements led to steep declines in stock prices of affected companies.
The investigation and negative financial disclosures could lead to lawsuits, affecting ARDT's market perception significantly.
Investors may react promptly to recent severe disclosures, leading to immediate impact on stock price.
SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Ardent Health, Inc. (NYSE:ARDT) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to disclose material information to investors.
Background of the Investigation
On November 12, 2025, Ardent issued a press release announcing its financial results for the third quarter of 2025. In connection with that release, the Company disclosed that it recorded a $43 million reduction in revenue due to a change in accounting estimates regarding the collectability of accounts receivable. Ardent also revealed a $54 million increase to its professional liability reserves related to claims arising in New Mexico. Following these disclosures, the trading price of the Company's common stock declined significantly during pre-market trading on November 13, 2025.
What if I purchased Ardent securities?
If you purchased ARDT securities and suffered losses, join our investigation now:
https://www.johnsonfistel.com/investigations/ardent-health/
For more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471. There is no cost or obligation to you.
About Johnson Fistel, PLLP | Top Law Firm, Securities Fraud, Investors Rights
Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. We also extend our services to foreign investors who purchased on U.S. exchanges. For more information, please visit http://www.johnsonfistel.com.
Achievements
In 2024, Johnson Fistel was honored to be ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services. The firm recovered approximately $90,725,000 for investors in cases where it served as lead or co-lead counsel. This marks the eighth time the firm has been recognized among the top securities law firms in the United States.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contact:
Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations (619) 814-4471
jimb@johnsonfistel.com
